{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T17:39:47Z","timestamp":1792517987122,"version":"4.5.0"},"reference-count":37,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Otolaryngol Head Neck Surg"],"published-print":{"date-parts":[[2024,7,1]]},"abstract":"<jats:sec id=\"ab-ooi240031-4\"><jats:title>Importance<\/jats:title><jats:p>Sinonasal squamous cell carcinoma (SNSCC) is the most commonly encountered cancer within the sinonasal cavity. Ongoing research has sought to ascertain the potential role of human papillomavirus (HPV) in the pathogenesis of SNSCC.<\/jats:p><\/jats:sec><jats:sec id=\"ab-ooi240031-5\"><jats:title>Objective<\/jats:title><jats:p>To assess trends in HPV-associated and HPV-independent SNSCC over time, including assessment of clinical demographics, treatment patterns, and survival.<\/jats:p><\/jats:sec><jats:sec id=\"ab-ooi240031-6\"><jats:title>Design, Setting, and Participants<\/jats:title><jats:p>This cohort study used patient data from the National Cancer Institute\u2019s Surveillance, Epidemiology, and End Results Program database between 1975 and 2018. Anatomic sites with a greater predilection for HPV positivity (ie, nasal cavity, ethmoid sinus) were used as a surrogate for HPV-associated SNSCC; meanwhile, patients with SNSCC in the other subsites were classified into the HPV-independent group. Data were analyzed from August 2022 to May 2023.<\/jats:p><\/jats:sec><jats:sec id=\"ab-ooi240031-7\"><jats:title>Main Outcomes and Measures<\/jats:title><jats:p>Clinical demographics and mortality trends over time were described for the HPV-associated and HPV-independent groups and further stratified according to stage on presentation.<\/jats:p><\/jats:sec><jats:sec id=\"ab-ooi240031-8\"><jats:title>Results<\/jats:title><jats:p>The study population consisted of 3752 patients with SNSCC (mean [SD] age at diagnosis, 65.7 [13.3] years; 2417 [64.4%] male), with 1983 (52.9%) having HPV-associated SNSCC and 1769 (47.1%) with HPV-independent SNSCC. Patients with HPV-associated subsites compared with patients with HPV-independent SNSCC were more likely to present with localized disease (838 [42.3%] vs 162 [9.2%]), whereas more patients in the HPV-independent group than HPV-associated group presented with regional disease (1018 [57.5%] vs 480 [24.2%]). Incidence-based mortality was stable over time within the HPV-associated group (0.32%) and, conversely, showed a significant decrease within the HPV-independent group (\u22122.29%). Patients with HPV-associated SNSCC had a higher 5-year overall survival when compared with the HPV-independent group (62% vs 35% [difference, 27 percentage points; 95% CI, 23-31 percentage points]). The better 5-year overall survival in the HPV-associated group vs HPV-independent group was present across all disease stages (localized: hazard ratio [HR], 2.67; 95% CI, 1.96-3.65; regional: HR, 1.53; 95% CI, 1.29-1.82; and distant: HR, 1.97; 95% CI, 1.52-2.55).<\/jats:p><\/jats:sec><jats:sec id=\"ab-ooi240031-9\"><jats:title>Conclusions and Relevance<\/jats:title><jats:p>This cohort study showed that the proportion of HPV-associated SNSCC rose over time associated with both a rise in the proportion of nasal cavity SNSCC and a decrease in HPV-independent maxillary sinus SNSCC. These data suggest that HPV-associated SNSCC has a distinct demographic and prognostic profile, given the improved survival seen in patients with HPV-associated SNSCC.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamaoto.2024.1311","type":"journal-article","created":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T15:33:47Z","timestamp":1717688027000},"page":"609","source":"Crossref","is-referenced-by-count":19,"title":["Epidemiologic Trends in Human Papillomavirus\u2013Associated Sinonasal Squamous Cell Carcinoma"],"prefix":"10.1001","volume":"150","author":[{"given":"Ameen","family":"Amanian","sequence":"first","affiliation":[{"name":"Department of Otolaryngology\u2013Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland"},{"name":"Division of Otolaryngology\u2013Head and Neck Surgery, Department of Surgery, The University of British Columbia Faculty of Medicine, Vancouver, British Columbia, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Ishii","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology\u2013Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland"},{"name":"Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Fakhry","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology\u2013Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Nyall R.","family":"London","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology\u2013Head and Neck Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland"},{"name":"Department of Neurosurgery, Johns Hopkins University School of Medicine, Baltimore, Maryland"},{"name":"Sinonasal and Skull Base Tumor Program, Surgical Oncology Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"key":"ooi240031r1","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/s40136-022-00404-7","article-title":"Human papillomavirus-related carcinomas of the sinonasal tract.","volume":"10","author":"Lopez","year":"2022","journal-title":"Curr Otorhinolaryngol Rep"},{"issue":"1","key":"ooi240031r2","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3322\/caac.21752","article-title":"The contemporary management of cancers of the sinonasal tract in adults.","volume":"73","author":"Thawani","year":"2023","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"ooi240031r3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijom.2013.07.741","article-title":"Sinonasal squamous cell carcinomas: clinical outcomes and predictive factors.","volume":"43","author":"Michel","year":"2014","journal-title":"Int J Oral Maxillofac Surg"},{"issue":"1","key":"ooi240031r4","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/lary.24264","article-title":"Epidemiology of sinonasal squamous cell carcinoma: a comprehensive analysis of 4994 patients.","volume":"124","author":"Sanghvi","year":"2014","journal-title":"Laryngoscope"},{"issue":"12","key":"ooi240031r5","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1002\/1097-0142(20011215)92:12<3012::AID-CNCR10131>3.0.CO;2-E","article-title":"Nasal and paranasal sinus carcinoma: are we making progress? a series of 220 patients and a systematic review.","volume":"92","author":"Dulguerov","year":"2001","journal-title":"Cancer"},{"issue":"11","key":"ooi240031r6","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1002\/cncr.33452","article-title":"Neoadjuvant chemotherapy for locoregionally advanced squamous cell carcinoma of the paranasal sinuses.","volume":"127","author":"Abdelmeguid","year":"2021","journal-title":"Cancer"},{"issue":"3","key":"ooi240031r7","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1055\/s-0041-1736160","article-title":"Induction chemotherapy for orbit preservation in sinonasal squamous cell carcinoma.","volume":"82","author":"Lilly","year":"2021","journal-title":"J Neurol Surg Rep"},{"issue":"7","key":"ooi240031r8","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/PAS.0000000000001871","article-title":"Is it time for a molecular-based classification system for sinonasal squamous cell carcinoma?","volume":"46","author":"Haas","year":"2022","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"ooi240031r9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3390\/cancers13010045","article-title":"Human papillomavirus in sinonasal squamous cell carcinoma: a systematic review and meta-analysis.","volume":"13","author":"Chang Sing Pang","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"15","key":"ooi240031r10","doi-asserted-by":"crossref","first-page":"3677","DOI":"10.3390\/cancers13153677","article-title":"Human papillomavirus and survival of sinonasal squamous cell carcinoma patients: a systematic review and meta-analysis.","volume":"13","author":"Sharma","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"3","key":"ooi240031r11","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/PAS.0000000000001410","article-title":"HPV-related sinonasal carcinoma: clinicopathologic features, diagnostic utility of p16 and Rb immunohistochemistry, and EGFR copy number alteration.","volume":"44","author":"Jiromaru","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"ooi240031r12","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.55971","article-title":"Evaluation of the incidence of human papillomavirus-associated squamous cell carcinoma of the sinonasal tract among US adults.","volume":"6","author":"London","year":"2023","journal-title":"JAMA Netw Open"},{"key":"ooi240031r13","doi-asserted-by":"crossref","first-page":"E1863","DOI":"10.1002\/hed.24336","article-title":"Geographic variation in human papillomavirus-related oropharyngeal cancer: data from 4 multinational randomized trials.","volume":"38","author":"Mehanna","year":"2016","journal-title":"Head Neck"},{"issue":"7","key":"ooi240031r14","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1002\/hed.26679","article-title":"Disparities and guideline adherence for HPV testing among patients with oropharyngeal squamous cell carcinoma, NCDB, and SEER.","volume":"43","author":"Husain","year":"2021","journal-title":"Head Neck"},{"issue":"11","key":"ooi240031r15","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1016\/j.annonc.2020.07.011","article-title":"Squamous cell carcinoma of the oral cavity, larynx, oropharynx and hypopharynx: EHNS-ESMO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up.","volume":"31","author":"Machiels","year":"2020","journal-title":"Ann Oncol"},{"issue":"32","key":"ooi240031r16","doi-asserted-by":"crossref","first-page":"4294","DOI":"10.1200\/JCO.2011.36.4596","article-title":"Human papillomavirus and rising oropharyngeal cancer incidence in the United States.","volume":"29","author":"Chaturvedi","year":"2011","journal-title":"J Clin Oncol"},{"issue":"1","key":"ooi240031r18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.ajo.2010.08.047","article-title":"Appropriate use and reporting of uncontrolled case series in the medical literature.","volume":"151","author":"Kempen","year":"2011","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"ooi240031r19","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1177\/0194599815593277","article-title":"Sinonasal carcinoma: racial and ethnic disparities in survival\u2014a review of 4714 patients.","volume":"153","author":"Smith","year":"2015","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"1","key":"ooi240031r21","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1037\/0033-2909.112.1.155","article-title":"A power primer.","volume":"112","author":"Cohen","year":"1992","journal-title":"Psychol Bull"},{"issue":"3","key":"ooi240031r22","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","article-title":"Permutation tests for joinpoint regression with applications to cancer rates.","volume":"19","author":"Kim","year":"2000","journal-title":"Stat Med"},{"issue":"12","key":"ooi240031r23","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/0895-4356(94)90089-2","article-title":"A method for partitioning cancer mortality trends by factors associated with diagnosis: an application to female breast cancer.","volume":"47","author":"Chu","year":"1994","journal-title":"J Clin Epidemiol"},{"issue":"7","key":"ooi240031r24","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1002\/cncr.32679","article-title":"Human papillomavirus and survival of patients with sinonasal squamous cell carcinoma.","volume":"126","author":"Oliver","year":"2020","journal-title":"Cancer"},{"issue":"9","key":"ooi240031r25","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1002\/cncr.34690","article-title":"High-risk human papillomavirus 16\/18 associated with improved survival in sinonasal squamous cell carcinoma.","volume":"129","author":"Ramkumar","year":"2023","journal-title":"Cancer"},{"issue":"12","key":"ooi240031r26","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1002\/cncr.24309","article-title":"Human papillomaviruses are identified in a subgroup of sinonasal squamous cell carcinomas with favorable outcome.","volume":"115","author":"Alos","year":"2009","journal-title":"Cancer"},{"issue":"2","key":"ooi240031r27","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/PAS.0b013e3182698673","article-title":"Human papillomavirus-related carcinomas of the sinonasal tract.","volume":"37","author":"Bishop","year":"2013","journal-title":"Am J Surg Pathol"},{"issue":"4","key":"ooi240031r28","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00428-015-1812-x","article-title":"The presence of high-risk human papillomavirus (HPV) E6\/E7 mRNA transcripts in a subset of sinonasal carcinomas is evidence of involvement of HPV in its etiopathogenesis.","volume":"467","author":"Laco","year":"2015","journal-title":"Virchows Arch"},{"issue":"8","key":"ooi240031r29","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1002\/hed.26134","article-title":"P16 and human papillomavirus in sinonasal squamous cell carcinoma.","volume":"42","author":"Cohen","year":"2020","journal-title":"Head Neck"},{"issue":"1","key":"ooi240031r30","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1097\/PAS.0000000000001566","article-title":"Clinicopathologic significance of EGFR mutation and HPV infection in sinonasal squamous cell carcinoma.","volume":"45","author":"Hongo","year":"2021","journal-title":"Am J Surg Pathol"},{"issue":"2","key":"ooi240031r31","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1093\/annonc\/mdx736","article-title":"Human papillomavirus (HPV) and somatic EGFR mutations are essential, mutually exclusive oncogenic mechanisms for inverted sinonasal papillomas and associated sinonasal squamous cell carcinomas.","volume":"29","author":"Udager","year":"2018","journal-title":"Ann Oncol"},{"key":"ooi240031r32","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2021.105620","article-title":"De-escalation studies in HPV-positive oropharyngeal cancer: how should we proceed?","volume":"123","author":"Golusinski","year":"2021","journal-title":"Oral Oncol"},{"issue":"6","key":"ooi240031r33","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1007\/s12250-021-00413-8","article-title":"Current status of human papillomavirus-related head and neck cancer: from viral genome to patient care.","volume":"36","author":"Dong","year":"2021","journal-title":"Virol Sin"},{"issue":"3","key":"ooi240031r34","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/CCO.0000000000000726","article-title":"Sinonasal cancers treatments: state of the art.","volume":"33","author":"Ferrari","year":"2021","journal-title":"Curr Opin Oncol"},{"issue":"11","key":"ooi240031r35","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1002\/lary.29568","article-title":"Socioeconomic factors affect presentation stage and survival in sinonasal squamous cell carcinoma.","volume":"131","author":"Jafari","year":"2021","journal-title":"Laryngoscope"},{"issue":"9","key":"ooi240031r36","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1097\/MLR.0000000000000073","article-title":"Comparison of SEER treatment data with Medicare claims.","volume":"54","author":"Noone","year":"2016","journal-title":"Med Care"},{"issue":"1","key":"ooi240031r37","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1001\/jamaoto.2022.3636","article-title":"Trends in incidence and mortality of larynx cancer in the US.","volume":"149","author":"Divakar","year":"2023","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"ooi240031r20","volume-title":"Statistical Power Analysis for the Behavioral Sciences","author":"Cohen","year":"1988","edition":"2nd ed"},{"key":"ooi240031r17","unstructured":"Surveillance, Epidemiology, and End Results Program. National Cancer Institute. Accessed April 30, 2024. http:\/\/www.seer.cancer.gov"}],"container-title":["JAMA Otolaryngology\u2013Head &amp; Neck Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaotolaryngology\/articlepdf\/2819315\/jamaotolaryngology_amanian_2024_oi_240031_1719860920.73499.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T15:44:01Z","timestamp":1720712641000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaotolaryngology\/fullarticle\/2819315"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,1]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaoto.2024.1311","relation":{},"ISSN":["2168-6181"],"issn-type":[{"value":"2168-6181","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,1]]}}}